Calcyon Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
CGS 21680 Hydrochloride | 124431-80-7 | sc-211062 sc-211062A | 10 mg 50 mg | $286.00 $1024.00 | 7 | |
CGS 21680 is an adenosine A2A receptor agonist that activates the A2A receptor, leading to downstream signaling pathways that inhibit Calcyon function. It indirectly reduces Calcyon-mediated dopamine receptor internalization. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram is a selective phosphodiesterase 4 (PDE4) inhibitor that increases intracellular cAMP levels. Elevated cAMP levels interfere with Calcyon-regulated receptor internalization. | ||||||
SCH-202676 hydrobromide | 70375-43-8 | sc-200835 sc-200835A | 10 mg 50 mg | $110.00 $434.00 | ||
SCH-202676 is an adenosine A2A receptor antagonist. By blocking the A2A receptor, it indirectly affects Calcyon-mediated dopamine receptor internalization. | ||||||
D-Serine | 312-84-5 | sc-391671 sc-391671A sc-391671B | 5 g 25 g 100 g | $42.00 $125.00 $200.00 | ||
D-Serine is an N-methyl-D-aspartate (NMDA) receptor co-agonist. Modulating NMDA receptors can influence Calcyon-associated receptor trafficking. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A | 50 mg 500 mg | $68.00 $357.00 | 11 | |
Clozapine is an atypical antipsychotic that interacts with various neurotransmitter receptors. Its effect on dopamine receptors can influence Calcyon-mediated receptor trafficking. | ||||||
CGP-20712A methanesulfonate salt | 105737-62-0 | sc-507239 | 10 mg | $315.00 | ||
CGP 20712A is a selective β1-adrenergic receptor antagonist. By blocking β1-adreceptors, it indirectly impacts Calcyon-associated dopamine receptor internalization. | ||||||
MPEP hydrochloride | 96206-92-7 | sc-279454A sc-279454 | 10 mg 50 mg | $133.00 $510.00 | ||
MPEP is a selective metabotropic glutamate receptor 5 (mGluR5) antagonist. It modulates glutamate receptors, potentially affecting Calcyon-related pathways. | ||||||
A-317491 | 475205-49-3 | sc-474921 | 5 mg | $150.00 | ||
A-317491 is a selective P2X3 and P2X2/3 receptor antagonist. Modulating purinergic receptors can influence Calcyon-associated receptor trafficking. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol is a typical antipsychotic that interacts with dopamine receptors. Its effect on dopamine receptors can impact Calcyon-mediated receptor endocytosis. | ||||||
CRAC Channel Inhibitor, BTP2 | 223499-30-7 | sc-221441 | 5 mg | $185.00 | 9 | |
YM-58483 is a store-operated calcium channel (CRAC) inhibitor. It affects calcium signaling pathways, potentially disrupting Calcyon-mediated functions. | ||||||